Sale!

Generic KRAS G12C NSCLC Inhibitor Tablets

Original price was: $197.00.Current price is: $38.00.

Adagrasib targets the KRAS G12C mutation. It’s mainly for NSCLC patients who have this specific mutation. The tablets are 200 mg each.

SKU: SKU67EWM5ECI Category: Tags: ,
Guaranteed Safe Checkout

Adagrasib targets the KRAS G12C mutation. It’s mainly for NSCLC patients who have this specific mutation. The tablets are 200 mg each.

You take 600 mg, twice a day. It doesn’t matter if you have them with food or not. Each bottle has 180 tablets.

Scroll to Top